Heart Disease Risk
FDA announces labeling changes on cholesterol drug Zocor
Published in Medical Letter on the CDC and FDA, May 11th, 2003
The new labeling will reflect research showing that simvastatin is effective in reducing risks of fatal and nonfatal heart attacks, strokes, and in reducing the need for bypass surgery and angioplasty. FDA approved Zocor in 1991 to lower cholesterol.
The Heart Protection Study was a double-blind, placebo-controlled study conducted in 20,536 patients. Men and women with heart disease or at high risk because of diabetes, peripheral arterial disease, or a history of stroke or other...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Severe Acute Respiratory Syndrome
CDC eyes possible workplace spread of SARS - Severe Acute Respiratory Syndrome
CDC lab sequences genome of new coronavirus - Blood Safety
American Red Cross agrees to revised consent decree - Dendritic Cells
Efficient gene transfer into dendritic cells accomplished by electroporation - Lung Cancer Risk Factor
Gene-environment interactions involving antioxidants influence lung cancer risk - Quality of Life
Elderly, disabled smokers report poorer health - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
